These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16267356)

  • 1. Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease.
    Johnson M
    Proc Am Thorac Soc; 2005; 2(4):320-5; discussion 340-1. PubMed ID: 16267356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease.
    Johnson M
    Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled therapy for stable chronic obstructive pulmonary disease.
    Antoniu SA; Mihaescu T; Donner CF
    Expert Opin Pharmacother; 2007 Apr; 8(6):777-85. PubMed ID: 17425473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Other forms of bronchodilation].
    Izquierdo Alonso JL; Malo de Molina R
    Arch Bronconeumol; 2004 Mar; 40 Suppl 1():23-9. PubMed ID: 16137446
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA; Donohue JF
    Proc Am Thorac Soc; 2007 Oct; 4(7):526-34. PubMed ID: 17878465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
    Wang ZL
    Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
    [No Abstract]   [Full Text] [Related]  

  • 10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of receptor targets in the lung.
    Barnes PJ
    Proc Am Thorac Soc; 2004; 1(4):345-51. PubMed ID: 16113456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD; Johnson M; Gan WQ; Man SF
    Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for chronic obstructive pulmonary disease: clinical aspects.
    Donohue JF
    Proc Am Thorac Soc; 2005; 2(4):272-81; discussion 290-1. PubMed ID: 16267348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
    Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
    Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.
    Belmonte KE
    Proc Am Thorac Soc; 2005; 2(4):297-304; discussion 311-2. PubMed ID: 16267352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drug therapy of chronic obstructive pulmonary disease].
    Kino H
    Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management--inhaled treatment.
    Currie GP; Lipworth BJ
    BMJ; 2006 Jun; 332(7555):1439-41. PubMed ID: 16777889
    [No Abstract]   [Full Text] [Related]  

  • 20. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.